8,332 Shares in Cardinal Health, Inc. $CAH Bought by Highland Capital Management LLC

Key Points

• Highland Capital Management established a new position in Cardinal Health (NYSE:CAH), purchasing 8,332 shares in Q4 valued at about $1.71 million.
• Cardinal Health beat quarterly EPS estimates ($3.17 vs. $2.79) and set FY2026 guidance of 10.70–10.80 EPS, while analysts maintain a consensus "Moderate Buy" with an average price target of $241.80 and several firms raising targets (Jefferies to $270).
• The company raised its quarterly dividend to $0.5158 (annualized $2.06, ~1.0% yield), and institutional investors now own about 87.17% of the stock.

Highland Capital Management LLC purchased a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 8,332 shares of the company's stock, valued at approximately $1,712,000.

Several other large investors also recently bought and sold shares of CAH. Integrated Wealth Concepts LLC increased its position in Cardinal Health by 6.9% in the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company's stock worth $601,000 after purchasing an additional 280 shares during the last quarter. Jones Financial Companies Lllp increased its position in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new position in Cardinal Health during the second quarter valued at $1,935,000. Cerity Partners LLC increased its position in Cardinal Health by 17.0% during the second quarter. Cerity Partners LLC now owns 40,426 shares of the company's stock valued at $6,792,000 after acquiring an additional 5,880 shares during the last quarter. Finally, Nebula Research & Development LLC increased its position in Cardinal Health by 34.4% during the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company's stock valued at $1,736,000 after acquiring an additional 2,646 shares during the last quarter. Institutional investors own 87.17% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Robert W. Baird set a $248.00 price objective on shares of Cardinal Health in a research report on Friday. Argus boosted their price objective on shares of Cardinal Health from $232.00 to $248.00 and gave the company a "buy" rating in a research report on Wednesday, February 11th. Zacks Research upgraded shares of Cardinal Health from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 12th. Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday. Finally, Jefferies Financial Group boosted their price objective on shares of Cardinal Health from $220.00 to $270.00 and gave the company a "buy" rating in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $241.80.

Cardinal Health Trading Down 0.0%

Shares of CAH opened at $196.97 on Wednesday. The firm has a market capitalization of $46.13 billion, a P/E ratio of 30.12, a P/E/G ratio of 1.17 and a beta of 0.53. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60. The firm has a fifty day moving average price of $213.19 and a 200-day moving average price of $206.47.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business's revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health's payout ratio is presently 31.19%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.